NCT00496847View on ClinicalTrials.gov

Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2009

Conditions
Intrabony Periodontal Defect
Interventions
DRUG

PERIOGEN

Implantation of rhPDGF-BB (0.3 mg/ml) + β-TCP (0.5 g)

DRUG

Beta TCP alone

Implantation of β-TCP (0.5 g) alone

Trial Locations (1)

501101

Sri Sai Dental college of surgery, Vikarabad,, RR Dist

All Listed Sponsors
lead

Virchow Group

INDUSTRY

NCT00496847 - Efficacy and Safety of PERIOGEN in the Treatment of Periodontal Bone Defect | Biotech Hunter | Biotech Hunter